Follow-up study of risk factors in progressive supranuclear palsy

被引:49
|
作者
Golbe, LI [1 ]
Rubin, RS [1 ]
Cody, RP [1 ]
Belsh, JM [1 ]
Duvoisin, RC [1 ]
Grosmann, C [1 ]
Lepore, FE [1 ]
Mark, MH [1 ]
Sachdeo, RC [1 ]
Sage, JI [1 ]
Zimmerman, TR [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT ENVIRONM & COMMUNITY MED, NEW BRUNSWICK, NJ 08903 USA
关键词
D O I
10.1212/WNL.47.1.148
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cause of progressive supranuclear palsy (PSP) is not known and has been little studied. The one previous controlled epidemiologic survey, performed at our center in 1986, found small-town experience and greater educational attainment as PSP risks, but, in retrospect, these results may have been produced by ascertainment bias. Since that time, several anecdotal reports have implicated heredity and various environmental exposures in the cause of some cases of PSP. To clarify the results of the previous study and to evaluate the more recently implicated candidate factors in a controlled fashion, we mailed a validated 69-item questionnaire to 91 personally examined patients with PSP and 104 unmatched controls with other neurologic conditions for which they had been referred to our tertiary neurologic center. We were able to match 75 subjects from each group by year of birth, sex, and race and subjected them to a separate matched-pair analysis. We allowed surrogates to supply any or all of the responses. Questions concerned hydrocarbon, pesticide, and herbicide exposure; urban/rural living; auto repair and other occupations; head trauma; educational attainment; maternal age; and family history of PSP, parkinsonism, dementia, and other neurologic conditions. A statistically significant finding was that patients with PSP there less likely to have completed at least 12 years of school (matched odds ratio = 0.35, 95% CI = 0.12-0.95, p = 0.022; unmatched odds ratio = 0.44, 95% CI = 0.21-0.89, p = 0.020). We hypothesize that this result may be a proxy for poor early-life nutrition or for occupational or residential exposure to an as-yet unsuspected toxin. Future studies should examine these potential risk factors in PSP.
引用
收藏
页码:148 / 154
页数:7
相关论文
共 50 条
  • [31] Progressive supranuclear palsy
    Karceski, Steven
    NEUROLOGY, 2008, 71 (22) : E70 - E72
  • [32] Adolescent Cardiovascular Risk Factors: A Follow-up Study
    Kilty, Heather Lee
    Prentice, Dawn
    CLINICAL NURSING RESEARCH, 2010, 19 (01) : 6 - 20
  • [33] Progressive supranuclear palsy
    Bartosova, T.
    Klempir, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (06) : 584 - 601
  • [34] Progressive Supranuclear Palsy
    Golbe, Lawrence I.
    SEMINARS IN NEUROLOGY, 2014, 34 (02) : 151 - 159
  • [35] PROGRESSIVE SUPRANUCLEAR PALSY
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1964, 188 (13): : 1148 - &
  • [36] Progressive supranuclear palsy
    Giagkou, Nikolaos
    Hoeglinger, Guenter U.
    Stamelou, Maria
    PARKINSONISM BEYOND PARKINSON'S DISEASE, 2019, 149 : 49 - 86
  • [37] Progressive supranuclear palsy
    Pahwa, R
    MEDICAL CLINICS OF NORTH AMERICA, 1999, 83 (02) : 369 - +
  • [38] Perry syndrome with progressive supranuclear palsy-like phenotype in a Portuguese family Long-term clinical follow-up
    Barreto, Rui Duarte
    Rodrigues, Rita
    Roriz, Jose Mario
    Alonso, Isabel
    Magalhaes, Marina
    PARKINSONISM & RELATED DISORDERS, 2021, 84 : 74 - 76
  • [39] Lifetime exposure to estrogen and risk for progressive supranuclear palsy
    Park, H. K.
    Litvan, I.
    Ilango, S.
    MOVEMENT DISORDERS, 2017, 32